PTPN11 and neoplasm: In addition, compared with the controls, GDC-0623 reduced tumor vascularization in SHP2-silenced B16F10 tumors (Figure 9, I and O), and the vessels appeared to have a reduced lumen, but were perfused (Supplemental Figure 10C).